Insider Trading activities of Seattle Genetics Inc /wa insiders. , Part 3

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Seattle Genetics Inc /wa since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Seattle Genetics Inc /wa since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Seattle Genetics Inc /wa since 2005. The reporting company's ticker symbol is SGEN. The reporting company's CIK number is 1060736.
The total value of stock buying since 2005 is $1,202,514,629.
The total value of stock sales since 2005 is $248,686,406.
The total value of stock option exercises since 2005 is $46,022,989.


 1   2   3   4 

Table 2. Detailed insider stock purchases, sales, and option exercises of Seattle Genetics Inc /wa insiders (SGEN) , Part 3
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-06-13 Himes Vaughn B (EVP, Tech. Ops. & Proc. Sci.) Sale 10,000 32.11 321,100
2013-06-13 Himes Vaughn B (EVP, Tech. Ops. & Proc. Sci.) Option Ex 10,000 9.23 92,300
2013-06-03 Siegall Clay B (President and CEO) Sale 2,000 33.88 67,762
2013-06-03 Siegall Clay B (President and CEO) Option Ex 2,000 10.33 20,660
2013-05-10 Akkaraju Srinivas (Director) Sale 17,500 37.17 650,422
2013-05-10 Akkaraju Srinivas (Director) Option Ex 17,500 12.76 223,300
2013-05-09 14159, L.p. (Director) Buy 138,073 34.14 4,713,950
2013-05-08 14159, L.p. (Director) Buy 233,055 34.18 7,965,586
2013-05-07 14159, L.p. (Director) Buy 117,254 33.65 3,946,066
2013-05-01 Siegall Clay B (President and CEO) Sale 2,000 36.58 73,152
2013-05-01 Siegall Clay B (President and CEO) Option Ex 2,000 10.33 20,660
2013-04-01 Siegall Clay B (President and CEO) Sale 2,000 35.53 71,062
2013-04-01 Siegall Clay B (President and CEO) Option Ex 2,000 10.33 20,660
2013-03-15 Boerner Christopher S. (SVP, Commercial) Sale 8,500 33.61 285,659
2013-03-15 Boerner Christopher S. (SVP, Commercial) Option Ex 8,500 15.10 128,350
2013-03-11 Dobmeier Eric (Chief Operating Officer) Sale 60,000 31.16 1,869,360
2013-03-11 Dobmeier Eric (Chief Operating Officer) Option Ex 50,000 12.08 604,000
2013-03-07 Simpson Todd E (Chief Financial Officer) Sale 49,718 30.73 1,527,684
2013-03-07 Simpson Todd E (Chief Financial Officer) Option Ex 20,176 11.62 234,546
2013-03-06 Dobmeier Eric (Chief Operating Officer) Sale 50,000 30.42 1,520,950
2013-03-06 Dobmeier Eric (Chief Operating Officer) Option Ex 50,000 12.00 600,000
2013-03-05 Dobmeier Eric (Chief Operating Officer) Sale 12,567 28.95 363,814
2013-03-05 Dobmeier Eric (Chief Operating Officer) Option Ex 12,567 12.16 152,814
2013-03-05 Siegall Clay B (President and CEO) Sale 68,750 28.87 1,984,950
2013-03-04 Dobmeier Eric (Chief Operating Officer) Sale 37,433 28.95 1,083,685
2013-03-04 Dobmeier Eric (Chief Operating Officer) Option Ex 37,433 12.16 455,185
2013-03-01 Siegall Clay B (President and CEO) Sale 27,000 28.22 761,886
2013-03-01 Siegall Clay B (President and CEO) Option Ex 2,000 10.33 20,660
2013-02-26 Gryska David W (Director) Option Ex 10,000 6.69 66,900
2013-02-25 Gryska David W (Director) Sale 10,000 27.17 271,700
2013-02-01 Siegall Clay B (President and CEO) Sale 2,000 29.61 59,216
2013-02-01 Siegall Clay B (President and CEO) Option Ex 2,000 10.33 20,660
2013-01-28 Reynolds Thomas C (Chief Medical Officer) Sale 5,207 30.19 157,188
2013-01-28 Reynolds Thomas C (Chief Medical Officer) Option Ex 5,207 12.11 63,041
2013-01-25 Reynolds Thomas C (Chief Medical Officer) Sale 2,083 29.84 62,154
2013-01-25 Reynolds Thomas C (Chief Medical Officer) Option Ex 2,083 15.46 32,203
2013-01-15 Reynolds Thomas C (Chief Medical Officer) Sale 125,079 28.00 3,502,712
2013-01-15 Reynolds Thomas C (Chief Medical Officer) Option Ex 125,079 12.15 1,519,459
2013-01-04 Dobmeier Eric (Chief Operating Officer) Sale 50,983 24.95 1,272,025
2013-01-04 Dobmeier Eric (Chief Operating Officer) Option Ex 60,000 11.09 665,400
2013-01-04 Siegall Clay B (President and CEO) Sale 2,000 25.05 50,104
2013-01-04 Siegall Clay B (President and CEO) Option Ex 2,000 10.33 20,660
2013-01-02 Siegall Clay B (President and CEO) Sale 6,249 23.83 148,938
2013-01-02 Siegall Clay B (President and CEO) Option Ex 6,249 3.30 20,621
2012-12-17 Dobmeier Eric (Chief Operating Officer) Sale 50,000 23.70 1,184,950
2012-12-17 Dobmeier Eric (Chief Operating Officer) Option Ex 62,418 10.53 657,074
2012-12-10 Reynolds Thomas C (Chief Medical Officer) Sale 6,588 25.75 169,641
2012-12-10 Reynolds Thomas C (Chief Medical Officer) Option Ex 6,588 10.69 70,425
2012-12-07 Reynolds Thomas C (Chief Medical Officer) Sale 30,000 25.77 773,070
2012-12-07 Reynolds Thomas C (Chief Medical Officer) Option Ex 30,000 10.29 308,700
2012-12-06 Reynolds Thomas C (Chief Medical Officer) Sale 30,000 25.77 772,980
2012-12-06 Reynolds Thomas C (Chief Medical Officer) Option Ex 30,000 12.16 364,800
2012-12-05 Reynolds Thomas C (Chief Medical Officer) Sale 10,000 25.60 256,000
2012-12-05 Reynolds Thomas C (Chief Medical Officer) Option Ex 10,000 12.16 121,600
2012-12-05 Lippman Marc E (Director) Sale 67,500 25.54 1,723,950
2012-12-05 Lippman Marc E (Director) Option Ex 67,500 6.89 465,007
2012-12-04 Reynolds Thomas C (Chief Medical Officer) Sale 30,000 25.58 767,490
2012-12-04 Reynolds Thomas C (Chief Medical Officer) Option Ex 30,000 12.11 363,210
2012-12-03 Reynolds Thomas C (Chief Medical Officer) Sale 10,000 25.45 254,500
2012-12-03 Reynolds Thomas C (Chief Medical Officer) Option Ex 10,000 12.16 121,600
2012-12-03 Welch Daniel G (Director) Option Ex 3,119 8.38 26,137
2012-12-03 Siegall Clay B (President and CEO) Sale 8,250 25.18 207,776
2012-12-03 Siegall Clay B (President and CEO) Option Ex 8,250 3.30 27,225
2012-11-30 Reynolds Thomas C (Chief Medical Officer) Sale 10,000 25.50 255,000
2012-11-30 Reynolds Thomas C (Chief Medical Officer) Option Ex 10,000 12.08 120,800
2012-11-29 Reynolds Thomas C (Chief Medical Officer) Sale 20,000 25.40 508,040
2012-11-29 Reynolds Thomas C (Chief Medical Officer) Option Ex 20,000 12.00 240,000
2012-11-26 Reynolds Thomas C (Chief Medical Officer) Sale 3,000 25.50 76,500
2012-11-26 Reynolds Thomas C (Chief Medical Officer) Option Ex 3,000 12.00 36,000
2012-11-23 Reynolds Thomas C (Chief Medical Officer) Sale 17,000 25.38 431,460
2012-11-23 Reynolds Thomas C (Chief Medical Officer) Option Ex 17,000 12.00 204,000
2012-11-21 Reynolds Thomas C (Chief Medical Officer) Sale 10,000 25.25 252,500
2012-11-21 Reynolds Thomas C (Chief Medical Officer) Option Ex 10,000 15.46 154,600
2012-11-20 Reynolds Thomas C (Chief Medical Officer) Sale 10,000 25.00 250,000
2012-11-20 Reynolds Thomas C (Chief Medical Officer) Option Ex 10,000 13.73 137,300
2012-11-19 Reynolds Thomas C (Chief Medical Officer) Sale 10,000 24.90 249,000
2012-11-19 Reynolds Thomas C (Chief Medical Officer) Option Ex 10,000 15.46 154,600
2012-11-13 Dobmeier Eric (Chief Operating Officer) Sale 27,327 23.59 644,780
2012-11-13 Dobmeier Eric (Chief Operating Officer) Option Ex 24,811 10.29 255,305
2012-11-08 Simpson Todd E (Chief Financial Officer) Option Ex 72,737 5.42 393,870
2012-11-08 Dobmeier Eric (Chief Operating Officer) Option Ex 34,575 6.44 222,801
2012-11-01 Siegall Clay B (President and CEO) Sale 8,250 25.51 210,474
2012-11-01 Siegall Clay B (President and CEO) Option Ex 8,250 6.82 56,223
2012-10-15 Dobmeier Eric (Chief Operating Officer) Sale 25,000 25.01 625,300
2012-10-15 Dobmeier Eric (Chief Operating Officer) Option Ex 25,000 10.29 257,249
2012-10-01 Siegall Clay B (President and CEO) Sale 8,250 26.59 219,342
2012-10-01 Siegall Clay B (President and CEO) Option Ex 8,250 6.82 56,223
2012-09-10 Himes Vaughn B (EVP, Tech. Ops. & Proc. Sci.) Sale 10,000 28.79 287,900
2012-09-10 Himes Vaughn B (EVP, Tech. Ops. & Proc. Sci.) Option Ex 10,000 9.23 92,300
2012-09-06 Reynolds Thomas C (Chief Medical Officer) Sale 48,540 29.75 1,444,065
2012-09-06 Reynolds Thomas C (Chief Medical Officer) Option Ex 48,540 8.24 399,969
2012-09-06 Simpson Todd E (Chief Financial Officer) Sale 50,000 28.97 1,448,500
2012-09-06 Simpson Todd E (Chief Financial Officer) Option Ex 50,000 12.16 608,000
2012-09-05 Simpson Todd E (Chief Financial Officer) Sale 45,000 27.97 1,258,650
2012-09-05 Simpson Todd E (Chief Financial Officer) Option Ex 45,000 11.62 523,125
2012-09-04 Siegall Clay B (President and CEO) Sale 8,250 26.54 218,955
2012-09-04 Siegall Clay B (President and CEO) Option Ex 8,250 6.82 56,223
2012-08-27 Simpson Todd E (Chief Financial Officer) Sale 31,000 26.97 836,070
2012-08-27 Simpson Todd E (Chief Financial Officer) Option Ex 31,000 10.69 331,390
2012-08-24 Simpson Todd E (Chief Financial Officer) Sale 14,000 26.97 377,580
2012-08-24 Simpson Todd E (Chief Financial Officer) Option Ex 14,000 10.29 144,060
2012-08-23 Berger Franklin M (Director) Option Ex 20,000 10.14 202,800
2012-08-16 Simpson Todd E (Chief Financial Officer) Sale 40,000 25.97 1,038,800
2012-08-16 Simpson Todd E (Chief Financial Officer) Option Ex 40,000 10.29 411,599
2012-08-13 Dobmeier Eric (Chief Operating Officer) Sale 25,000 24.01 600,300
2012-08-10 Gryska David W (Director) Option Ex 7,500 5.00 37,500
2012-08-02 Siegall Clay B (President and CEO) Sale 458 25.22 11,550
2012-08-02 Siegall Clay B (President and CEO) Option Ex 458 3.30 1,511
2012-08-01 Siegall Clay B (President and CEO) Sale 7,792 26.04 202,911
2012-08-01 Siegall Clay B (President and CEO) Option Ex 7,792 6.82 53,102
2012-07-27 Welch Daniel G (Director) Option Ex 3,000 19.02 57,060
2012-07-02 Siegall Clay B (President & CEO) Sale 8,250 25.36 209,203
2012-07-02 Siegall Clay B (President & CEO) Option Ex 8,250 6.82 56,223
2012-06-18 Dobmeier Eric (Chief Operating Officer) Sale 25,000 25.36 634,000
2012-06-18 Dobmeier Eric (Chief Operating Officer) Option Ex 25,000 10.29 257,249
2012-06-14 Simpson Todd E (Chief Financial Officer) Sale 50,000 24.97 1,248,500
2012-06-14 Simpson Todd E (Chief Financial Officer) Option Ex 50,000 5.42 270,750
2012-06-12 Simpson Todd E (Chief Financial Officer) Sale 45,000 23.97 1,078,785
2012-06-12 Simpson Todd E (Chief Financial Officer) Option Ex 45,000 5.20 234,000
2012-06-12 Rosenberg Morris (EVP, Process Sciences) Sale 10,000 24.00 240,000
2012-06-12 Rosenberg Morris (EVP, Process Sciences) Option Ex 10,000 10.29 102,899
2012-06-08 Simpson Todd E (Chief Financial Officer) Sale 35,000 22.97 803,950
2012-06-08 Simpson Todd E (Chief Financial Officer) Option Ex 35,000 5.20 182,000
2012-06-07 Rosenberg Morris (EVP, Process Sciences) Sale 13,566 22.50 305,235
2012-06-07 Rosenberg Morris (EVP, Process Sciences) Option Ex 13,566 10.29 139,594
2012-06-05 Gryska David W (Director) Sale 8,000 19.75 158,000
2012-05-18 Rosenberg Morris (EVP, Process Sciences) Sale 64,800 21.30 1,380,240
2012-05-18 Rosenberg Morris (EVP, Process Sciences) Option Ex 64,800 4.45 288,360
2012-05-16 Rosenberg Morris (EVP, Process Sciences) Sale 200 20.80 4,160
2012-05-16 Rosenberg Morris (EVP, Process Sciences) Option Ex 200 4.45 890
2012-05-15 Reynolds Thomas C (Chief Medical Officer) Sale 949 19.75 18,742
2012-05-15 Reynolds Thomas C (Chief Medical Officer) Option Ex 949 8.24 7,819
2012-04-25 Reynolds Thomas C (Chief Medical Officer) Sale 40,000 19.75 790,000
2012-04-25 Reynolds Thomas C (Chief Medical Officer) Option Ex 40,000 8.24 329,600
2012-04-25 Dobmeier Eric (Chief Operating Officer) Sale 25,000 19.95 498,750
2012-04-25 Dobmeier Eric (Chief Operating Officer) Option Ex 25,000 10.24 256,124
2012-04-20 Rosenberg Morris (EVP, Process Sciences) Sale 38,281 19.51 746,862
2012-04-20 Rosenberg Morris (EVP, Process Sciences) Option Ex 38,281 5.63 215,522
2012-04-17 Rosenberg Morris (EVP, Process Sciences) Sale 44,219 18.88 834,854
2012-04-17 Rosenberg Morris (EVP, Process Sciences) Option Ex 44,219 5.82 257,487
2012-03-22 Reynolds Thomas C (Chief Medical Officer) Sale 40,000 19.78 791,120
2012-03-22 Reynolds Thomas C (Chief Medical Officer) Option Ex 40,000 8.24 329,600
2012-03-19 Reynolds Thomas C (Chief Medical Officer) Sale 37,700 19.75 744,575
2012-03-19 Reynolds Thomas C (Chief Medical Officer) Option Ex 37,700 8.24 310,648
2012-03-19 Lippman Marc E (Director) Option Ex 7,500 4.97 37,275
2012-03-16 Reynolds Thomas C (Chief Medical Officer) Sale 2,300 19.75 45,425
2012-03-16 Reynolds Thomas C (Chief Medical Officer) Option Ex 2,300 8.24 18,952
2012-03-13 Rosenberg Morris (EVP, Process Sciences) Sale 69,626 18.59 1,294,138
2012-03-13 Rosenberg Morris (EVP, Process Sciences) Option Ex 69,626 7.35 511,890
2012-02-28 Dobmeier Eric (Chief Operating Officer) Sale 46,000 18.52 851,920
 1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of SGEN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Seattle Genetics Inc /wa (symbol SGEN, CIK number 1060736) see the Securities and Exchange Commission (SEC) website.